Cerus CorporationCerus CorporationCerus Corporation

Cerus Corporation

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪214.96 M‬EUR
−0.085EUR
‪−20.21 M‬EUR
‪174.14 M‬EUR
‪179.15 M‬
Beta (1Y)
1.96
Employees (FY)
281
Change (1Y)
−7 −2.43%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About Cerus Corporation


CEO
William Mariner Greenman
Website
Headquarters
Concord
Founded
1991
ISIN
US1570851014
FIGI
BBG000KSP1H7
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Check out other big names from the same industry as CU2.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Cerus Corporation stocks are traded under the ticker CU2.
We've gathered analysts' opinions on Cerus Corporation future price: according to them, CU2 price has a max estimate of 4.45 EUR and a min estimate of 3.56 EUR. Watch CU2 chart and read a more detailed Cerus Corporation stock forecast: see what analysts think of Cerus Corporation and suggest that you do with its stocks.
CU2 reached its all-time high on Jul 9, 2001 with the price of 92.500 EUR, and its all-time low was 0.389 EUR and was reached on Dec 17, 2008. View more price dynamics on CU2 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Cerus Corporation financials in yearly and quarterly reports right on TradingView.
Cerus Corporation is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
CU2 earnings for the last quarter are −0.03 EUR per share, whereas the estimation was −0.02 EUR resulting in a −9.09% surprise. The estimated earnings for the next quarter are −0.02 EUR per share. See more details about Cerus Corporation earnings.
Cerus Corporation revenue for the last quarter amounts to ‪51.02 M‬ EUR, despite the estimated figure of ‪46.16 M‬ EUR. In the next quarter, revenue is expected to reach ‪49.35 M‬ EUR.
CU2 net income for the last quarter is ‪−4.84 M‬ EUR, while the quarter before that showed ‪−7.13 M‬ EUR of net income which accounts for 32.08% change. Track more Cerus Corporation financial stats to get the full picture.
No, CU2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 2, 2025, the company has 281 employees. See our rating of the largest employees — is Cerus Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cerus Corporation EBITDA is ‪−28.35 M‬ EUR, and current EBITDA margin is −18.46%. See more stats in Cerus Corporation financial statements.
Like other stocks, CU2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cerus Corporation stock right from TradingView charts — choose your broker and connect to your account.